Search for:
Author

Ren Jun Lim

Browsing
Ren Jun Lim is a principal with Baker McKenzie Wong & Leow. He represents local and international clients in both contentious and non-contentious intellectual property matters. He also advises on a full range of healthcare, as well as consumer goods-related legal and regulatory issues. Ren Jun co-leads Baker McKenzie Wong & Leow's Healthcare as well as Consumer Goods & Retail industry groups. He sits on the Law Society of Singapore IP Committee and on the Executive Committee of the Association of Information Security Professionals. He is also a member of the Vaccines Working Group, Singapore Association of Pharmaceutical Industries, a member of the International Trademark Association, as well as a member of the Regulatory Affairs Professionals Association. Ren Jun is ranked in the Silver tier for Individuals: Enforcement and Litigation and Individuals: Prosecution and Strategy, and a recommended lawyer for Individuals: Transactions by WTR 1000, 2020. He is also listed in Asia IP's Best 50 IP Expert, 2020, recognised as a Rising Star by Managing IP: IP Stars, 2019 and one of Singapore's 70 most influential lawyers aged 40 and under by Singapore Business Review, 2016. Ren Jun was acknowledged by WTR 1000 as a "trademark connoisseur who boasts supplementary knowledge of regulatory issues in the consumer products industry." He was also commended by clients for being "very responsive to enquiries and with a keen eye for detail, he is extremely hands-on. His meticulous and in-depth approach to strategising is key to the excellent outcomes we enjoy."

The Ministry of Health (MOH) has confirmed its intention to table the Health Information Bill (Bill) in the second half of 2023. Through the Bill, the MOH seeks to enable the collection of patients’ selected health data from healthcare providers and to allow healthcare providers to share patient information with one another in a safe and secure manner.

Following the implementation of the Healthcare Services Act in phases since January 2020, the Ministry of Health announced the first and second reading of the Healthcare Services (Amendment) Bill (Bill) on 6 February 2023 and 6 March 2023 respectively. If passed, most of the amendments as set out in the Bill will be implemented together with the second phase of implementation of the Healthcare Services Act in mid-2023.

The Carbon Pricing (Amendment) Act 2022 (“Act”), which came into force on 7 March 2023 and amends the Carbon Pricing Act 2018, seeks to advance Singapore’s transition towards net-zero.
The Act aims to encourage emitters of greenhouse gases to proactively reduce emissions by:
(a) progressively increasing carbon tax rates;
(b) introducing an industry transition framework to provide transitory allowances to companies in Emissions-Intensive Trade-Exposed sectors;
(c) setting up an International Carbon Credits framework; and
(d) revising the list of greenhouse gases and their Global Warming Potential Values.

From 31 January 2023, the Info-Communications Media Development Authority implemented the full SSIR regime. All organizations that use short message service (SMS) with sender identification are required to register their Sender IDs with the Singapore SMS Sender ID Registry. Non-registered SMSes have been labelled as “Likely-SCAM” and will be blocked from later this year. Organizations are encouraged to register their Sender IDs if they have not done so.

On 20 February 2023, the Health Sciences Authority announced that it had seized over 737,000 units of illegal health products worth SGD 640,000 in 2022 through enforcement raids and covert purchases. Illegal health products include unregistered or counterfeit health products, as well as products with potent medicinal ingredients and/or banned substances illegally added to them.